A detailed history of State Of Wisconsin Investment Board transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 53,989 shares of CRSP stock, worth $2.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
53,989
Previous 55,271 2.32%
Holding current value
$2.55 Million
Previous $2.99 Million 15.04%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$44.62 - $62.75 $57,202 - $80,445
-1,282 Reduced 2.32%
53,989 $2.54 Million
Q2 2024

Aug 14, 2024

BUY
$51.17 - $68.18 $28,143 - $37,499
550 Added 1.01%
55,271 $2.99 Million
Q1 2024

May 14, 2024

SELL
$60.67 - $89.12 $424,872 - $624,107
-7,003 Reduced 11.35%
54,721 $3.73 Million
Q4 2023

Feb 12, 2024

SELL
$38.62 - $72.18 $44,876 - $83,873
-1,162 Reduced 1.85%
61,724 $3.86 Million
Q3 2023

Nov 14, 2023

SELL
$45.39 - $59.0 $102,309 - $132,986
-2,254 Reduced 3.46%
62,886 $2.85 Million
Q2 2023

Aug 14, 2023

SELL
$43.47 - $67.77 $150,667 - $234,890
-3,466 Reduced 5.05%
65,140 $3.66 Million
Q1 2023

May 15, 2023

SELL
$41.0 - $56.12 $235,094 - $321,792
-5,734 Reduced 7.71%
68,606 $3.1 Million
Q4 2022

Feb 14, 2023

SELL
$39.19 - $65.67 $23,435 - $39,270
-598 Reduced 0.8%
74,340 $3.02 Million
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $226,497 - $310,572
-3,707 Reduced 4.71%
74,938 $4.9 Million
Q2 2022

Aug 15, 2022

BUY
$43.23 - $73.83 $1.2 Million - $2.06 Million
27,845 Added 54.81%
78,645 $4.78 Million
Q1 2022

May 13, 2022

BUY
$53.19 - $79.24 $2.7 Million - $4.03 Million
50,800 New
50,800 $3.19 Million
Q4 2021

Feb 11, 2022

SELL
$70.09 - $111.29 $1.61 Million - $2.56 Million
-22,961 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$110.2 - $156.64 $2.53 Million - $3.6 Million
22,961 New
22,961 $2.57 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.69B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.